Article Versions Notes

Tsai C-C, Su Y-C, Bamodu OA, Chen B-J, Tsai W-C, Cheng W-H, Lee C-H, Hsieh S-M, Liu M-L, Fang C-L, et al. High-Grade B-Cell Lymphoma (HGBL) with MYC and BCL2 and/or BCL6 Rearrangements Is Predominantly BCL6-Rearranged and BCL6-Expressing in Taiwan. Cancers. 2021; 13(7):1620. https://doi.org/10.3390/cancers13071620

Tsai, Cheng-Chih, Yung-Cheng Su, Oluwaseun Adebayo Bamodu, Bo-Jung Chen, Wen-Chiuan Tsai, Wei-Hong Cheng, Chii-Hong Lee, Shu-Min Hsieh, Mei-Ling Liu, Chia-Lang Fang, and et al. 2021. "High-Grade B-Cell Lymphoma (HGBL) with MYC and BCL2 and/or BCL6 Rearrangements Is Predominantly BCL6-Rearranged and BCL6-Expressing in Taiwan" Cancers 13, no. 7: 1620. https://doi.org/10.3390/cancers13071620

Tsai, C. -C., Su, Y. -C., Bamodu, O. A., Chen, B. -J., Tsai, W. -C., Cheng, W. -H., Lee, C. -H., Hsieh, S. -M., Liu, M. -L., Fang, C. -L., Lin, H. -T., Chen, C. -L., Yeh, C. -T., Lee, W. -H., Ho, C. -L., Lai, S. -W., Tzeng, H. -E., Hsieh, Y. -Y., Chang, C. -L., ... Chao, T. -Y. (2021). High-Grade B-Cell Lymphoma (HGBL) with MYC and BCL2 and/or BCL6 Rearrangements Is Predominantly BCL6-Rearranged and BCL6-Expressing in Taiwan. Cancers, 13(7), 1620. https://doi.org/10.3390/cancers13071620